Cleared Traditional

K234029 - CEFALY Connected - OTC, CEFALY Connected - Rx
(FDA 510(k) Clearance)

Jul 2024
Decision
211d
Days
Class 2
Risk

K234029 is an FDA 510(k) clearance for the CEFALY Connected - OTC, CEFALY Connected - Rx. This device is classified as a Stimulator, Nerve, Electrical, Transcutaneous, For Migraine (Class II - Special Controls, product code PCC).

Submitted by Cefaly Technology (Seraing, BE). The FDA issued a Cleared decision on July 18, 2024, 211 days after receiving the submission on December 20, 2023.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5891. Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin..

Submission Details

510(k) Number K234029 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2023
Decision Date July 18, 2024
Days to Decision 211 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code PCC — Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5891
Definition Used To Apply An Electrical Current To A Patient's Cranium Through Electrodes Placed On The Skin.

Similar Devices — PCC Stimulator, Nerve, Electrical, Transcutaneous, For Migraine

All 16
ELEXIR 2.0 (ALLIVE3)
K242719 · Nu Eyne Co., Ltd. · Nov 2024
DOOPANG
K232749 · Ybrain, Inc. · Jun 2024
Milieve (YPS-301BD)
K233751 · Soterix Medical, Inc. · Jun 2024
TENS device-HeadaTerm 2 (Model: YF-HT2)
K230782 · Wat Medical Technology, Inc. · Feb 2024
Cefaly Dual Enhanced with RFID - OTC, Cefaly Dual Enhanced with RFID - Rx, Cefaly Dual Connected - OTC, Cefaly Dual Connected - Rx
K212071 · Cefaly Technology · Dec 2022
Relivion
K212106 · Neurolief , Ltd. · Aug 2021